Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication

Published on Jan 1, 1998in Prevention & Treatment
· DOI :10.1037/1522-3736.1.1.12a
Irving Kirsch72
Estimated H-index: 72
,
Guy Sapirstein3
Estimated H-index: 3
Sources
Abstract
Mean effect sizes for changes in depression were calculated for 2,318 patients who had been randomly assigned to either antidepressant medication or placebo in 19 double-blind clinical trials. As a proportion of the drug response, the placebo response was constant across different types of medication (75%), and the correlation between placebo effect and drug effect was .90. These data indicate that virtually all of the variation in drug effect size was due to the placebo characteristics of the studies. The effect size for active medications that are not regarded to be antidepressants was as large as that for those classified as antidepressants, and in both cases, the inactive placebos produced improvement that was 75% of the effect of the active drug. These data raise the possibility that the apparent drug effect (25% of the drug response) is actually an active placebo effect. Examination of pre–post effect sizes among depressed individuals assigned to no-treatment or wait-list control groups suggest that approximately one quarter of the drug response is due to the administration of an active medication, one half is a placebo effect, and the remaining quarter is due to other nonspecific factors.
Figures & Tables
Download
📖 Papers frequently viewed together
200441.84Science
2,045 Citations
901 Citations
1,088 Citations
References74
Newest
#1R. Bruce SloaneH-Index: 9
#2Fred R. StaplesH-Index: 9
Last. Katherine WhippleH-Index: 6
view all 5 authors...
392 Citations
#1John E. Hunter (MSU: Michigan State University)H-Index: 63
#2Frank L. SchmidtH-Index: 73
PART I: INTRODUCTION TO META-ANALYSIS 1. Integrating Research Finding Across Studies 2. Study Artifacts and Their Impact on Study Outcomes PART II: META-ANALYSIS OF CORRELATIONS 3. Meta-Analysis of Correlations Corrected Individually for Artifacts 4. Meta-Analysis of Correlations Using Artifact Distributions 5. Technical Questions In Meta-Analysis of Correlations PART III: META-ANALYSIS OF EXPERIMENTAL EFFECTS AND OTHER DICHOTOMOUS COMPARISONS 6. Treatment Effects: Experimental Artifacts and The...
4,079 Citations
#1Anne HarringtonH-Index: 15
The placebo effect - is it much ado about nothing?, Arthur K. Shapiro and Elaine Shapiro clinical reflections on the placebo phenomenon, Howard Spiro the nocebo phenomenon - scope and foundations, Robert A. Hahn the doctor as therapeutic agent - a placebo effect research agenda, Howard Brody toward a neurobiology of placebo analgesia, Howard L. Fields and Donald D. Price the contribution of desire and expectation to placebo analgesia - implications for new research strategies, Donald D. Price an...
273 Citations
#1Roger P. Greenberg (SU: Syracuse University)H-Index: 21
#2Seymour FisherH-Index: 30
Last. Seymour FisherH-Index: 6
view all 2 authors...
34 Citations
#1Seymour FisherH-Index: 30
#1Seymour FisherH-Index: 6
Last. Roger P. GreenbergH-Index: 21
view all 2 authors...
Partial table of contents: CONCEPTUAL ISSUES. The Curse of the Placebo: Fanciful Pursuit of a Pure Biological Therapy (S. Fisher & R. Greenberg). Treatment Implications of Psychiatric Comorbidity (M. Greenberg). Costly Compromises: A Critique of the Diagnostic and Statistical Manual of Mental Disorders (R. Carson). EFFICACIES OF PSYCHOACTIVE DRUGS FOR ADULTS. A Critique of the Use of Neuroleptic Drugs in Psychiatry (D. Cohen). A Focused Empirical Analysis of Treatments for Panic and Anxiety (W. ...
70 Citations
#1Irving KirschH-Index: 72
147 Citations
#1Russell T. Joffe (McMaster University)H-Index: 27
#2Stephen T.H. Sokolov (McMaster University)H-Index: 6
Last. David L. Streiner (McMaster University)H-Index: 90
view all 3 authors...
Objective:To carry out a metaanalysis of antidepressant studies to calculate the effect sizes for antidepressant effect in depressive disorder.Method:A metaanalysis of all antidepressant studies that included an active comparison drug as well as placebo was used to calculate the effect size. Articles were selected from a MEDLINE search for the period January 1966 to June 1995. Forty-nine studies were included in the metaanalysis.Results:The effect sizes for antidepressant treatment are moderatel...
100 CitationsSource
#1Roger P. Greenberg (SU: Syracuse University)H-Index: 21
#2Robert F. BornsteinH-Index: 41
Last. Michael D. GreenbergH-Index: 3
view all 5 authors...
A meta-analysis was conducted on all the double-blind, placebo-controlled efficacy trials of the antidepressant fluoxetine (Prozac). This drug has become the antidepressant most frequently prescribed by psychiatrists and has been hailed by the media as a “wonder drug.” Results produced a relatively modest overall effect size that was no greater than effect sizes obtained by previous meta-analyses of tricyclic antidepressants. This study also examined the possibility that bias may have contaminat...
89 CitationsSource
Background: Venlafaxine is a new phenylethylamine antidepressant that exhibits monoamine reuptake inhibition. The current study evaluates the efficacy of venlafaxine compared to that of imipramine in outpatients suffering from major depression of moderate-tomarked severity. Method: We conducted a double-blind, placebo-controlled, 6-week treatment study of 224 outpatients who met DSM-III-R criteria for major depression, and who had a score of at least 20 on the 21-item Hamilton Rating Scale for D...
116 Citations
#1Carolyn K. Maynard (UNCC: University of North Carolina at Charlotte)H-Index: 4
#1Carolyn K. Maynard (UNCC: University of North Carolina at Charlotte)H-Index: 1
Abstract The purpose of this study was to evaluate the effectiveness of a structured cognitive-behavioral group intervention designed by Verona Gordon to reduce depression in women. An experimental three group pretest and posttest design was used. Women were randomly assigned to the structured and support groups. The structured group was found to be significantly more effective in reducing depression, hopelessness, anxiety, and improving self-esteem than either the support or untreated control g...
41 CitationsSource
Cited By422
Newest
#1Flavius R. W. Lilly (UMB: University of Maryland, Baltimore)H-Index: 3
#2Hyun-Jin Jun (UMB: University of Maryland, Baltimore)H-Index: 4
Last. Carol Vidal (Johns Hopkins University)H-Index: 3
view all 7 authors...
Background Untreated depression is associated with negative behavioral, psychosocial, and physical outcomes leading to socioeconomic costs, disability, and premature mortality. Research has not yet fully developed intervention models to increase the utilization of mental health treatments. The objective of the current study was to characterize the pathways linking health beliefs to treatment utilization among depressed young adults. Methods Data were collected in 2017 from 53,760 college student...
Source
#1Julia W. Haas (University of Marburg)
Last. Bettina K. DoeringH-Index: 14
view all 5 authors...
Abstract Background Meta-analyses demonstrate that placebo effects play an important role in antidepressant treatment. Expectations seem to constitute a highly relevant placebo mechanism in this context. This study investigated whether an expectation manipulation combined with the intake of an active placebo could reduce acute sadness in depressed participants following a sadness-inducing mood manipulation. Methods Women who suffered from a major depressive episode (N = 94) were randomly allocat...
1 CitationsSource
#1Lea Rebstock (University of Marburg)
#2Leonora N. Schäfer (University of Marburg)
Last. Winfried Rief (University of Marburg)H-Index: 69
view all 5 authors...
Abstract Background Rumination is a risk factor for the development and maintenance of depressive symptoms and represents an important target for the treatment of depression. In the present study, we aimed to examine whether rumination can be reduced when participants are led to believe that they would receive medication that would prevent them from ruminating. Methods In healthy participants (N= 91), an initial dysphoric state was induced via mood-suggestive music and autobiographic recall. Sub...
Source
#1Katja Weimer (University of Ulm)H-Index: 14
#2Paul EnckH-Index: 46
Last. Luana Colloca (UMB: University of Maryland, Baltimore)H-Index: 42
view all 4 authors...
1 CitationsSource
#1Xin Guo (WHU: Wuhan University)H-Index: 1
#2Robert McCutcheon ('KCL': King's College London)H-Index: 19
Last. Oliver D. Howes (Imperial College London)H-Index: 61
view all 7 authors...
Abstract OBJECTIVE To determine the relative variability and magnitude of symptomatic improvement in antidepressant-treated individuals compared to placebo-treated individuals, and to investigate moderating factors. METHODS Multiple database and previous publications were searched through February 2019 to identify all randomized controlled trials comparing placebo and antidepressants in acute treatment of depression. Primary outcome was relative variability of change in symptom severity in antid...
1 CitationsSource
#1A. Jon Stoessl (UBC: University of British Columbia)H-Index: 51
Abstract The placebo effect in many areas of neurological therapeutics is common and prominent. The importance of the response means that any new treatment must account for the placebo effect, but this in turn raises major challenges as to how to conduct scientifically meaningful research in an ethically acceptable fashion. Basic principles that may be in tension with one another are those of beneficence and respect for autonomy. It may be challenging to respect autonomy if the scientific design...
Source
#1Kristen L. Syme (Washington State University Vancouver)H-Index: 2
#2Edward H. Hagen (Washington State University Vancouver)H-Index: 21
The germ theory of disease and the attendant public health initiatives, including sanitation, vaccination, and antibiotic treatment, led to dramatic increases in global life expectancy. As the prevalence of infectious disease declines, mental disorders are emerging as major contributors to the global burden of disease. Scientists understand little about the etiology of mental disorders, however, and many of the most popular psychopharmacological treatments, such as antidepressants and antipsycho...
2 CitationsSource
What happens when we, as a profession, forget our past, whether it is what history and research have taught or the values that motivated us to become healers? Here, I explore this question. First, ...
Source
#1Dongmei He (North Sichuan Medical College)H-Index: 1
#2Binghu Jiang (North Sichuan Medical College)H-Index: 2
Last. Morgan A. McClure (North Sichuan Medical College)H-Index: 10
view all 5 authors...
OBJECTIVES: The placebo response to orexin receptor antagonists in primary insomnia is little-known. Our aim was, therefore, to conduct a systematic review of placebo-controlled randomized clinical trials to characterize placebo response. METHODS: We performed a comprehensive literature search for randomized, placebo-controlled, double-blind clinical trials evaluating the efficacy of orexin receptor antagonists addressing primary insomnia. To pool effect size estimates (Cohen's d) of placebo and...
Source